BTIG analyst David Larsen upgraded Progyny (PGNY) to Buy from Neutral with a $28 price target
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGNY:
- Progyny launches Parent and Child Well-being Offering
- Progyny’s Promising Growth Amidst Uncertainty: Hold Rating Maintained
- Progyny, Inc. Reports Strong 2024 Earnings with Optimistic Outlook
- Progyny’s Strong Q4 Results Amid Competitive Challenges and Uncertain Demand: Hold Rating Maintained
- Progyny price target raised to $34 from $30 at BofA
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue